| Date | Title (click to read) |
|---|---|
| March 4, 2010 | NPS Pharmaceuticals to Present at Cowen and Company Annual Health Care Conference |
| March 3, 2010 | NPS Pharmaceuticals to Report 2009 Financial Results |
| March 2, 2010 | NPS Pharmaceuticals Receives $38.4 Million for Sale of REGPARA Royalty Rights |
| February 26, 2010 | NPS Pharmaceuticals Announces Support for Rare Disease Day Observance |
| February 2, 2010 | NPS Pharmaceuticals to Present at BIO CEO & Investor Conference |
For a complete list of press releases, click here »
Notice to Readers
The reports filed by NPS with the Securities and Exchange Commission and the news releases issued by NPS and posted on this website are current only as of the dates on which they were filed or issued by NPS. Therefore, the contents of these reports and releases can become outdated. We make no commitment, and disclaim any duty, to update these reports and releases. We do not warrant the accuracy or completeness of these materials or the reliability of any advice, opinion, statement or other information displayed or distributed through the website. Readers acknowledge that any reliance on these reports, releases, advice, opinions, statements, or information are at the reader's sole risk.
Stay Informed
To stay apprised of NPS Pharmaceuticals financial reports and SEC filings as they are posted, sign up for Financial Alerts or SEC Alerts via email notification.